Page last updated: 2024-08-21

prenylamine and Benign Neoplasms

prenylamine has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdel-Qadir, H; Amir, E; Fazelzad, R; Lee, DS; Ong, G; Thavendiranathan, P; Tomlinson, G	1
Alé, J; Buceta, JE; Marantz, A; Milei, J; Vazquez, A	1

Reviews

1 review(s) available for prenylamine and Benign Neoplasms

Article	Year
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 03-01, Volume: 28, Issue:3 Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left	2017

Article

Year

Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis.

Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 03-01, Volume: 28, Issue:3

Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left

2017

Trials

1 trial(s) available for prenylamine and Benign Neoplasms

Article	Year
Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study. Cancer drug delivery, 1987, Volume: 4, Issue:2 Topics: Aged; Cardiomyopathies; Doxorubicin; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Neoplasms; Prenylamine; Prospective Studies; Random Allocation	1987